Search Results

ENGAGE Analysis Supports Medtronic's Endurant Stent Graft for EVAR in Short and Standard Neck Lengths

April 29, 2015—Medtronic plc announced that Prof.

First European Patients Enrolled in Study of Medtronic's Endurant Evo AAA Stent Graft System

August 7, 2015—Medtronic plc announced that the first two European cases in the clinical study of its Endurant Evo abdominal aortic aneurysm (AAA) stent graft system were successfully performed by European Principal Investigator Prof.

Long-Term Data Presented for Medtronic's Endurant AAA Stent Graft

April 18, 2014—Medtronic, Inc. (Santa Rosa, CA) announced that new clinical data supporting the company’s Endurant abdominal aortic aneurysm (AAA) stent graft system were presented at the 35th Charing Cross International Symposium, which was held April 5–8 in London, United Kingdom.

Medtronic's Endurant System Continues to Show Positive Outcomes With New ENGAGE Registry Data

November 15, 2016–Medtronic announced that data from new subanalyses of the company’s ENGAGE Global Registry were presented at the 2016 VEITHsymposium being held November 15­–19, 2016 in New York, NY.

Analysis of Medtronic's ENGAGE Registry Presented at Charing Cross Symposium

April 9, 2013—Medtronic, Inc. (Minneapolis, MN) announced that a new analysis of clinical data on the company's Endurant abdominal aortic aneurysm (AAA) stent graft system demonstrated consistent performance in treating AAAs across a range of patient anatomies, from relatively straightforward to highly complex.

ESVS 2021 Annual Meeting Will Be a Hybrid Event in Rotterdam

September 1, 2021—The European Society for Vascular Surgery (ESVS) announced that the ESVS 35th annual meeting on September 28-29 in Rotterdam, the Netherlands, is now planned as a hybrid event with sessions held both on-site in Rotterdam and online.

Medtronic’s Endurant AAA Stent Graft Studied at 10 Years in Completed ENGAGE OUS Registry

April 26, 2023—Medtronic announced data demonstrating the long-term durability of its Endurant abdominal aortic aneurysm stent graft system in a real-world setting.

Study Begins for Medtronic's Endurant Evo AAA Stent Graft System

April 27, 2015—Medtronic plc recently began a clinical study to evaluate the safety and effectiveness of the Endurant Evo abdominal aortic aneurysm (AAA) endovascular stent graft system.

Medtronic’s Endurant II/IIs EVAR Device to Be Evaluated in the Global ADVANCE Postmarket Randomized Trial

January 11, 2023—Medtronic announced the commencement of the ADVANCE trial, a global postmarket study of the company’s Endurant II/IIs bifurcated stent graft system, which is indicated for the endovascular treatment of infrarenal abdominal aortic or aorto-iliac aneurysms.